Sayvaa Pharma Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$3M
- Investors
-
1
Sayvaa Pharma General Information
Description
Developer of an oral formulation pharmaceutical designed for anti-viral treatment. The company focuses on developing novel formulations of proven drug products to improve properties and expand the scope, enabling healthcare professionals to treat patients suffering from coronavirus.
Contact Information
Corporate Office
- DE
- United States
Corporate Office
- DE
- United States
Sayvaa Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Mar-2021 | $3M | Completed | Startup |
Sayvaa Pharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| New Rhein Healthcare | Venture Capital | Minority |
Sayvaa Pharma FAQs
-
When was Sayvaa Pharma founded?
Sayvaa Pharma was founded in 2020.
-
Where is Sayvaa Pharma headquartered?
Sayvaa Pharma is headquartered in DE.
-
What industry is Sayvaa Pharma in?
Sayvaa Pharma’s primary industry is Drug Discovery.
-
Is Sayvaa Pharma a private or public company?
Sayvaa Pharma is a Private company.
-
What is Sayvaa Pharma’s current revenue?
The current revenue for Sayvaa Pharma is .
-
How much funding has Sayvaa Pharma raised over time?
Sayvaa Pharma has raised $3M.
-
Who are Sayvaa Pharma’s investors?
New Rhein Healthcare has invested in Sayvaa Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process